Bugbox & Med. Co. Kft.
- Address
- lock Available on a paid plan
Bugbox & Med. Co. Kft. - Respiratory Disease Research
Bugbox & Med. Co. Kft. is a specialized clinical research center focused on advancing therapeutic interventions for chronic respiratory diseases. The center demonstrates particular expertise in conducting sophisticated multi-arm clinical trials evaluating novel treatment approaches for patients with complex pulmonary conditions, including investigations into both combination therapies and innovative biological agents.
- Chronic Obstructive Pulmonary Disease (COPD) management and exacerbation prevention
- Triple and dual bronchodilator therapy combinations with corticosteroids
- Cardiopulmonary outcomes assessment in respiratory disease
- Novel biological therapies and monoclonal antibodies for respiratory conditions
The research center's portfolio emphasizes evaluating severe cardiopulmonary outcomes and exacerbation rates in symptomatic COPD populations. Their trials assess both established combination inhaler therapies, such as budesonide, glycopyrronium, and formoterol fumarate, as well as emerging treatments like tozorakimab as add-on therapy to standard of care. This dual focus on optimizing existing treatment regimens and exploring cutting-edge therapeutic options positions the center at the forefront of respiratory medicine research.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1AstraZeneca AB1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Bugbox & Med. Co. Kft.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Budesonide, Glycopyrronium Bromide, and Formoterol Fumarate on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease Patients | AstraZeneca AB | Phase III | Recruiting | Jul 2024 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Formoterol Fumarate Dihydrate | 2 | Unknown | 2024-07-04 | 2026-04-13 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.